Moreover, p53 can inhibit cancer cell proliferation, tumour growth and NSCLC development as the key mediator activating pyroptosis via upregulation of NLRP3, ASC and cleaved caspase-1 (ref. [84]). The gene discussed is TP53; the disease is non-small cell lung carcinoma.